OCGN Q2 2020 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$710M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$43,000

Gross Profit

-$2M-3690.7% margin

Operating Income

-$3M-7827.9% margin

Net Income

-$4M-8404.7% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$24M

Total Liabilities

$9M

Stockholders' Equity

$15M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$43,000	$0	—
Gross Profit	-$2M	-$1M	-28.0%
Operating Income	-$3M	-$3M	-10.0%
Net Income	-$4M	-$3M	-11.7%